Ruti Aga and the six-year ban: a fake prescription from a clinic that never existed

In March, Ruti Aga won a half marathon staged in China. Her sample came back positive for methylprednisolone. Cases of that shape usually close with a two-year suspension and a familiar script: an athlete treating a knee injury, caught out by a prohibited substance. The final decision from the Athletics Integrity Unit (AIU) ran to six years, effective 10 September. The four-year difference sits inside a single sheet of paper. That sheet was a prescription signed by a relative of Aga's. The clinic named on it confirmed to the AIU that no doctor by that name had ever worked there. The signatory said she had used an old prescription pad from a former workplace, and that workplace confirmed it had never employed her. Three independent verification steps, three identical answers. The cover-up was so amateurish that the amateurism itself became evidence. Aga is 32, Ethiopian, the 2026 Tokyo Marathon champion and a three-time runner-up at World Marathon Majors races. That record places her in the leading group of women's marathon running across the 2026-2026 window, a long way from the fringe. She also belongs to the East African cohort that regularly accepts invitations to Chinese road races, where appearance fees are the second-largest income stream after prize money. Methylprednisolone is a synthetic glucocorticoid, class S9 under the WADA list, prohibited in-competition only and classified as a Specified Substance — a category acknowledged to be more plausibly tied to therapeutic use or inadvertence. Much of the reporting called it a "steroid", which pushes readers toward anabolic agents, a different family of compounds altogether. For a glucocorticoid, a runner with a knee injury is entitled to apply for a Therapeutic Use Exemption, a TUE. Aga said she injected the drug because of her knee. The AIU handled the case along two tracks. Track one: a prohibited substance in the sample, two-year baseline. Track two: falsifying documents during results management, four-year baseline. The WADA Code requires independent violations to be served consecutively rather than concurrently, so two plus four becomes six. The penalty for the forgery is double the penalty for the substance itself. Across 34 years of watching the track, I once sat in the technical meeting room of a national athletics meet and heard a coach ask the medical officer a direct question: if one of his athletes needed a corticosteroid injection three days before a final, where does the exemption paperwork come from? The answer was vague enough that I wrote it down verbatim and have kept it since. Aga ran into the same void, with far more money behind it. Data does not discriminate by gender. Only prejudice does. The WADA list applies to women's marathon runners and men's marathon runners identically, line by line, sanction by sanction. There is one place where the record goes quiet, and I have to say so plainly. The statement discloses no time for the March half marathon. Without that figure I cannot place the performance against world rankings, cannot compare it with her personal best, cannot judge whether it was heavy or light in sporting terms. I never issue a judgment before looking at the number. Even when instinct says otherwise. The only thing readable from that race is its economic role: an appearance-fee event, staged outside any championship structure, built for invited guests. The ordinary side of a runner's life is easier to measure. The women's marathon peak commonly stretches to 35, sometimes 38. A six-year ban returns Aga to competition at 38, after six years without racing, without ranking points, without invitations. The probability of climbing back onto a World Marathon Majors podium after that gap is close to zero. This sanction ends a career, and it lands precisely on the years when that career was worth the most. For Ethiopian athletics, the systemic damage is barely measurable. The country's road-running pipeline is deep enough that a vacated slot fills within a season. Aga is one mesh in the densest net in the world, and the net does not tear because of one mesh. The counterintuitive part of the case is the ordering inside the sentence. The public looks at it and sees an athlete who took a banned substance. The AIU looked at it and saw a forged file. Had Aga told the truth about the knee injection, applied for a retroactive TUE or accepted a two-year sanction, her story would have settled into the therapeutic-error category — the kind of case athletics meets several times a year. She chose otherwise, and the otherwise cost three times as much. Responsibility does not stop with a 32-year-old. The case exposes a structural gap: runners inside the East African road-racing pipeline rarely have compliance counsel, rarely have anyone reading the prohibited list aloud before they sign. Someone helped Aga rebuild her story — the relative, possibly the management layer behind her. That layer, as I keep saying about the transfer market, is the largest hidden cost in sport: it generates the noise, it takes the commission, and the athlete carries the error. How the press handled the chemistry deserves a line too. Calling methylprednisolone a "steroid" inflates the severity above what the molecule actually is, and erases the most important part of the story: a treatment drug that is legal with paperwork became a six-year ban because the paperwork was fake. When the stands are empty, I hear my own echo more clearly. In the Aga case the empty stand was the hearing room, and the echo was three confirmation letters from three different places, all saying the same thing. A remark that was ignored years ago becomes a lecture for the next generation. The lecture fits in one sentence: athletes are allowed to make mistakes, but they are punished hardest for how they meet those mistakes. For Vietnamese athletics, where young runners increasingly compete abroad and where appearance-fee invitationals are increasingly common, the skill of filing a TUE and the habit of declaring honestly deserve to be taught as early as running technique. If one of our 20-year-olds wakes up tomorrow needing a corticosteroid injection for a swollen knee, does she know who to call before she signs the form?